Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001544406-13-000001
Filing Date
2013-03-14
Accepted
2013-03-14 12:34:03
Documents
1
Effectiveness Date
2013-03-14
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9656
  Complete submission text file 0001544406-13-000001.txt   10800
Mailing Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022
Business Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022 212-891-1100
Valence Advantage Life Sciences Fund II, L.P. (Filer) CIK: 0001544406 (see all company filings)

EIN.: 454660146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-174950 | Film No.: 13689743